Total number (n)
|
112 |
111 |
114 |
Age (years)
|
42.76 ± 8.65 |
40.45 ± 9.42 |
40.41 ± 9.42 |
Body weight (kg)
|
92.61 ± 22.86 |
90.89 ± 18.86 |
88.54 ± 20.34 |
Body mass index (kg m
−2
)
|
30.97 ± 7.29 |
29.59 ± 5.96 |
29.33 ± 6.73 |
Waist‐to‐hip‐ratio
|
0.95 ± 0.09 |
0.95 ± 0.08 |
0.94 ± 0.07 |
Alanine transferase (ALT, U/L)
|
29.06 ± 20.09 |
29.88 ± 21.01 |
28.54 ± 23.58 |
Aspartate transferase (AST, U/L)
|
21.65 ± 8.5 |
23.14 ± 12.13 |
20.99 ± 8.66 |
Creatinine clearance (CRCL, ml min
−1
)
|
122.69 ± 46.91 |
121.91 ± 32.68 |
122.62 ± 39.77 |
Gender (% male)
|
81 (72.3) |
93 (83.78) |
84 (73.6) |
Ethnicity
|
|
|
|
Not Hispanic or Latino
|
101 (90.1%) |
104 (93.6%) |
104 (91.2%) |
Other
|
11 (9.8%) |
7 (6.3%) |
10 (8.7%) |
Race
|
|
|
|
Black or African American
|
84 (75%) |
79 (71.1%) |
80 (70.1%) |
Other
|
28 (25%) |
32 (28.8%) |
34 (29.8%) |
CYP2D6 genotype metabolizer
|
|
|
|
Extensive
|
92 (82.1%) |
98 (88.2%) |
97 (85.0%) |
Intermediate
|
8 (7.1%) |
4 (3.6%) |
7 (6.1%) |
Poor
|
3 (2.6%) |
1 (0.9%) |
3 (2.6%) |
Inconclusive
|
8 (7.1%) |
7 (6.3%) |
6 (5.2%) |
Missing
|
1 (0.9%) |
1 (0.9%) |
1 (0.8%) |
Dopamine D2 receptor (DRD2) genotype (rs1801028)
|
|
|
|
GG
|
106 (94.6%) |
108 (97.2%) |
113 (99.1%) |
GC
|
5 (4.4%) |
2 (1.8%) |
0 (0%) |
Missing
|
1 (0.9%) |
1 (0.9%) |
1 (0.9) |
Serotonin 2C receptor (5‐HT2C) genotype (rs3813929)
|
|
|
|
CC
|
102 (91.0%) |
102 (91.9%) |
104 (91.2%) |
CT
|
4 (3.6%) |
4 (3.6%) |
3 (2.6%) |
TT
|
5 (4.4%) |
4 (3.6%) |
6 (5.2%) |
Missing
|
1 (0.9%) |
1 (0.9%) |
1 (0.9%) |
Serotonin 2A receptor (5‐HT2A) genotype (rs6313)
|
|
|
|
CC
|
44 (39.2%) |
45 (40.5%) |
43 (37.7%) |
CT
|
55 (49.1%) |
49 (44.1%) |
48 (42.1%) |
TT
|
12 (10.7%) |
15 (13.5%) |
22 (19.2%) |
Inconclusive
|
0 (0%) |
1 (0.9%) |
0 (0%) |
Missing
|
1 (0.9%) |
1 (0.9%) |
1 (0.9%) |
Melanocortin 4 receptor (MCR4) genotype (rs17782313)
|
|
|
|
CC
|
9 (8.0%) |
9 (8.1%) |
11.4 (85.0%) |
TC
|
48 (42.8%) |
55 (49.5%) |
27.1 (6.1%) |
TT
|
54 (48.2%) |
46 (41.4%) |
60.5 (2.6%) |
Missing
|
1 (0.9%) |
1 (0.9%) |
1 (0.9%) |